Enveda

AI-enabled drug discovery company that mines chemistry from natural sources to develop small-molecule medicines.

View on the globe

$461MEquity raised in 2025–20262025 $150M · 2026 $311M · 2 equity rounds
$516MEquity raised, all time3 equity rounds sourced so far
$2BLatest valuationpost-money, as reported

Rounds over time log-scaled amounts

Funding history: 3 rounds from 14 Jun 2024 to 23 Sep 2026, $516M equity disclosed, latest valuation $2B. Earlier rounds exist but are not sourced.14 Jun 2024: Series B2, $55M; 4 Sep 2025: Series D, $150M; 23 Sep 2026: Series E, $311M, valued at $2B$10M$30M$100M$300M$1B$3BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 201920252026Equity roundPost-money valuation23 Sep 2026 · Series E · valued at $2B23 Sep 2026 · Series E · $311M at $2B · led by Catalio Capital Management4 Sep 2025 · Series D · $150M · led by Premji Invest14 Jun 2024 · Series B2 · $55M$2BSeries E · $311MSeries D · $150MSeries B · $55M
Funding history: 3 rounds from 14 Jun 2024 to 23 Sep 2026, $516M equity disclosed, latest valuation $2B. Earlier rounds exist but are not sourced.14 Jun 2024: Series B2, $55M; 4 Sep 2025: Series D, $150M; 23 Sep 2026: Series E, $311M, valued at $2B$10M$30M$100M$300M$1B$3BEarlier rounds exist but are not sourced yetearlier rounds not sourced’1920252026Equity roundValuation23 Sep 2026 · Series E · valued at $2B23 Sep 2026 · Series E · $311M at $2B · led by Catalio Capital Management4 Sep 2025 · Series D · $150M · led by Premji Invest14 Jun 2024 · Series B2 · $55M$2B$311M$150M$55M

Funding history 3 rounds · 5 sources · newest first

Earlier rounds not yet sourced. Enveda was founded in 2019 and raised before 14 Jun 2024; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series E
    Amount$311M
    Post-money$2B
    ✓ Confirmed
    Lead
    Catalio Capital Management
    Also
    ICONIQ
    Note
    Valuation of $2B reported by TechCrunch only (pre/post-money not stated); Crunchbase News confirms amount and lead and says total raised exceeds $845M. The Series C ($130M, Nov 2024, extended to $150M in Feb 2025) is listed on the company newsroom but not yet recorded here.
    Sources
  2. Series D
    Amount$150M
    Post-money—
    ✓ Confirmed
    Lead
    Premji Invest
    Also
    Baillie Gifford, Kinnevik, Exor, Peakline Partners, FPV, Socium Ventures, Dimension, Level Ventures, Henry Kravis, IA Ventures, Lux Capital
    Note
    Oversubscribed round; headline says it reaches unicorn status but no valuation figure is stated, so left null. Company says total raised is $517M including the $150M Series C closed in February 2025 (Sanofi). Release does not say which investors are new versus existing.
    Sources
  3. Series B2
    Amount$55M
    Post-money—
    ◔ Reported
    Also
    Microsoft, The Nature Conservancy, Premji Invest, Exor, Kinnevik, True Ventures, FPV, Level Ventures, Jazz Venture Partners
    Note
    No lead named in the article; TechCrunch says total raised reached $230M.
    Sources
  4. Earlier rounds not yet sourced

Investors 18

  • Premji Invest2
  • Catalio Capital Management1
  • Exor2
  • FPV2
  • Kinnevik2
  • Level Ventures2
  • Baillie Gifford
  • Dimension
  • Henry Kravis
  • IA Ventures
  • ICONIQ
  • Jazz Venture Partners
  • Lux Capital
  • Microsoft
  • Peakline Partners
  • Socium Ventures
  • The Nature Conservancy
  • True Ventures

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Enveda and its logo are trademarks of their owners, used here for identification only.